GD2 Positive Glioma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients (NCT03252171) | Fuda Cancer Hospital, Guangzhou | 2015-10-15 |
Track GD2 Positive Glioma automatically
Every clearance here is in the API, with alerts when new ones post.